Smith Chas P & Associates PA Cpas raised its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 66.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 269,954 shares of the company's stock after buying an additional 108,108 shares during the period. Procter & Gamble makes up about 2.0% of Smith Chas P & Associates PA Cpas' investment portfolio, making the stock its 22nd largest holding. Smith Chas P & Associates PA Cpas' holdings in Procter & Gamble were worth $38,687,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of the stock. E Fund Management Hong Kong Co. Ltd. raised its stake in Procter & Gamble by 1,000.0% during the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock valued at $25,000 after purchasing an additional 150 shares during the period. Park Square Financial Group LLC raised its stake in Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock valued at $26,000 after purchasing an additional 71 shares during the period. Maseco LLP acquired a new stake in Procter & Gamble during the 4th quarter valued at $28,000. Saranac Partners Ltd acquired a new stake in Procter & Gamble during the 3rd quarter valued at $30,000. Finally, Caitlin John LLC acquired a new stake in Procter & Gamble during the 3rd quarter valued at $34,000. Institutional investors own 65.77% of the company's stock.
Analysts Set New Price Targets
PG has been the topic of several recent analyst reports. Weiss Ratings reissued a "hold (c)" rating on shares of Procter & Gamble in a research note on Friday, March 27th. The Goldman Sachs Group cut their target price on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 8th. Jefferies Financial Group cut their target price on shares of Procter & Gamble from $179.00 to $175.00 and set a "buy" rating on the stock in a research note on Monday, April 20th. Barclays lowered their price target on shares of Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 14th. Finally, Raymond James Financial lowered their price target on shares of Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating on the stock in a report on Tuesday, April 14th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $161.06.
Check Out Our Latest Report on PG
Insider Transactions at Procter & Gamble
In related news, CEO Ma. Fatima Francisco sold 5,549 shares of the company's stock in a transaction on Friday, February 27th. The shares were sold at an average price of $165.29, for a total value of $917,194.21. Following the completion of the sale, the chief executive officer directly owned 1,029 shares in the company, valued at approximately $170,083.41. This represents a 84.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble News Summary
Here are the key news stories impacting Procter & Gamble this week:
Procter & Gamble Trading Up 3.2%
Procter & Gamble stock opened at $147.52 on Thursday. The company's fifty day simple moving average is $144.58 and its 200-day simple moving average is $147.92. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $170.99. The stock has a market cap of $343.52 billion, a P/E ratio of 21.57, a P/E/G ratio of 6.13 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. The business had revenue of $21.24 billion for the quarter, compared to analysts' expectations of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. Procter & Gamble's revenue was up 7.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were issued a $1.0885 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date was Friday, April 24th. Procter & Gamble's dividend payout ratio is currently 63.60%.
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.